FDA Adverse Event Injury Summary report: N

STARCLOSE SE VASCULAR CLOSURE SYSTEM

MDR report key: 6870964 · Received September 15, 2017

Report

Report Number
2024168-2017-07505
Event Type
Injury
Date Received
September 15, 2017
Date of Event
August 25, 2017
Report Date
November 29, 2017
Manufacturer
AV-TEMECULA-CT
Product Code
MGB
PMA / PMN Number
P050007
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INTERNAL FILE NUMBER - (B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. PER THE STARCLOSE SE INSTRUCTIONS FOR USE: THE STARCLOSE SE VASCULAR CLOSURE SYSTEM SHOULD BE USED ONLY BY OPERATORS TRAINED IN DIAGNOSTIC AND INTERVENTIONAL CATHETERIZATION PROCEDURES WHO HAVE BEEN CERTIFIED BY AN AUTHORIZED REPRESENTATIVE OF ABBOTT VASCULAR INC. THE CUSTOMER REPORTED THE DEVICE WAS DISCARDED. INVESTIGATION IS NOT YET COMPLETE. A FOLLOW UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICE WAS NOT RETURNED FOR ANALYSIS, WHICH WOULD HAVE AIDED IN DETERMINATION OF THE ROOT CAUSE. DIFFICULTY OR FAILURE TO DEPLOY THE CLIP APPEARS TO BE RELATED TO THE INABILITY TO FULLY SPLIT THE SHEATH. THE MOST PROBABLE CAUSE FOR THE DIFFICULT OR FAILURE TO SPLIT THE SHEATH IS RELATED TO THE MATERIAL USED TO MANUFACTURE THE SHEATH. A REVIEW OF THE COMPLAINT HANDLING DATABASE FOUND SIMILAR INCIDENTS FROM THIS LOT REPORTED FOR DIFFICULTY OR FAILURE TO SPLIT THE SHEATH. ABBOTT VASCULAR (AV) CONDUCTED ROOT CAUSE ANALYSIS AND DETERMINED THE ISSUE MAY BE RELATED TO MANUFACTURING. THE ISSUE IS BEING ADDRESSED PER INTERNAL OPERATING PROCEDURES. AV WILL CONTINUE TO TREND THE PERFORMANCE OF THESE DEVICES.

Description of Event or Problem · 1

IT WAS REPORTED THAT ARTERIOTOMY CLOSURE OF THE RIGHT COMMON FEMORAL ARTERY WAS ATTEMPTED USING A STARCLOSE SE DEVICE WITH A 6FR SHEATH AFTER A PULMONARY TUMOR EMBOLISM INTERVENTIONAL PROCEDURE. REPORTEDLY, IT WAS DIFFICULT TO PERFORM STEP 3 (SPLITTING THE SHEATH). IT TAKES MORE STRENGTH TO TEAR THE INTRODUCER SHEATH. A PLASTIC STRIP FROM THE INTRODUCER SHEATH DETACHED FROM THE SHEATH AND WAS REMOVED FROM THE PUNCTURE SITE WITH HEMOSTATIC FORCEPS. STARCLOSE SE CLIP CLOSURE WAS NOT SATISFACTORY; MANUAL ARTERIAL COMPRESSION WAS USED TO ACHIEVE HEMOSTASIS. THERE WAS NO REPORTED ADVERSE PATIENT SEQUELA OR CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE OR THERAPY. THE PHYSICIAN IS REPORTEDLY NOT TRAINED IN THE USE OF THE STARCLOSE SE DEVICE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
648664 STARCLOSE SE VASCULAR CLOSURE SYSTEM IMPLANTABLE CLIP MGB AV-TEMECULA-CT 7031441

Patients

Seq Age Sex Outcome Treatment
1 56 YR Required Intervention